KORU Medical Systems (KRMD) Stock Forecast, Price & News

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for KORU Medical Systems in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" KRMD shares.
View KRMD analyst ratings or view top-rated stocks.

4 Wall Street analysts have issued twelve-month price objectives for KORU Medical Systems' shares. Their KRMD share price forecasts range from $3.00 to $4.50. On average, they expect the company's share price to reach $3.88 in the next twelve months. This suggests a possible upside of 43.5% from the stock's current price.
View analysts price targets for KRMD or view top-rated stocks among Wall Street analysts.

KORU Medical Systems' stock was trading at $3.57 at the beginning of 2023. Since then, KRMD stock has decreased by 24.4% and is now trading at $2.70.
View the best growth stocks for 2023 here.

KORU Medical Systems saw a increase in short interest in the month of September. As of September 15th, there was short interest totaling 338,900 shares, an increase of 7.7% from the August 31st total of 314,700 shares. Based on an average daily volume of 89,500 shares, the short-interest ratio is presently 3.8 days. Approximately 0.8% of the shares of the stock are short sold.
View KORU Medical Systems' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 8th 2023.
View our KRMD earnings forecast.

KORU Medical Systems, Inc. (NASDAQ:KRMD) issued its earnings results on Wednesday, August, 9th. The company reported ($0.05) EPS for the quarter, meeting analysts' consensus estimates of ($0.05). The business earned $6.94 million during the quarter, compared to analysts' expectations of $6.93 million. KORU Medical Systems had a negative trailing twelve-month return on equity of 26.65% and a negative net margin of 27.55%.

KORU Medical Systems issued an update on its FY 2023 earnings guidance on Thursday, August, 10th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $31.00 million-$32.50 million, compared to the consensus revenue estimate of $31.51 million.

Based on aggregate information from My MarketBeat watchlists, some companies that other KORU Medical Systems investors own include NVIDIA (NVDA), Enphase Energy (ENPH), Alibaba Group (BABA), Walt Disney (DIS), PennyMac Financial Services (PFSI), Inseego (INSG), Micron Technology (MU), Advanced Micro Devices (AMD), Marvell Technology (MRVL) and Taiwan Semiconductor Manufacturing (TSM).

KORU Medical Systems trades on the NASDAQ under the ticker symbol "KRMD."

Shares of KRMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of KRMD stock can currently be purchased for approximately $2.70.

KORU Medical Systems (NASDAQ:KRMD) has a market capitalization of $123.23 million and generates $27.90 million in revenue each year. The company earns $-8,660,000.00 in net income (profit) each year or ($0.17) on an earnings per share basis.

KORU Medical Systems' mailing address is 24 CARPENTER RD, CHESTER NY, 10918. The official website for the company is www.korumedical.com. The company can be reached via phone at (845) 469-2042, via email at dsullivan@equityny.com, or via fax at 845-469-5518.